pfizer nyse - Search News

Pfizer Stock Jumps on Q4 Beats

Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4

Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results , with sales up 21.9% year on year to $17.76 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.

Investing · 1d

Pfizer stock rises after beating Q4 expectations

Pfizer (NYSE: PFE) posted adjusted earnings per share of $0.63 for Q4, exceeding the analyst consensus of $0.48. Revenue came in at $17.8 billion, above expectations of $17.28 billion.

Business Insider · 1d

PFE Earnings: Pfizer Stock Jumps on Q4 Beats

Pfizer (PFE) stock is up today after the pharmaceutical company reported earnings for the fourth quarter of 2024. The company’s adjusted EPS of

SFGate · 1d

Pfizer: Q4 Earnings Snapshot

The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 48 cents per share. The drugmaker posted revenue of $17.76 billion in the period, also exceeding Street forecasts.

Zacks.com on MSN · 1d

Pfizer (PFE) Beats Q4 Earnings and Revenue Estimates

Pfizer (PFE) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items.

8hon MSN

Goldman Sachs cuts Pfizer stock price target to $32 from $33

The anticipation surrounding dose optimization data for Pfizer (NYSE:PFE)'s obesity treatment, danuglipron, was also mentioned as a point of interest for the first quarter. However, the analyst ...

13h

Pfizer Inc (PFE) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements

Pfizer Inc (PFE) reports robust financial performance with significant revenue growth and strategic progress in oncology and ...

DZ BANK AG Sticks to Its Buy Rating for Pfizer (PFE)

In a report released today, Elmar Kraus from DZ BANK AG maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares opened ...

2don MSN

Pfizer Q4 Earnings Preview: Strong top line growth expected on COVID-19 product demand

Pfizer (PFE) is set to announce Q4 earnings, with analysts expecting a $0.46 profit per share and $17.26B revenue.

Pfizer (NYSE:PFE) Takes On Some Risk With Its Use Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows ...

3don MSN

Here’s Why Pfizer Inc. (PFE) Is Among the Best Dividend Stocks Under $30

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive The Stock Down

Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...

The Pharma Letter1d

Pfizer beats sales and earnings forecast in 4th-qtr

US pharma giant Pfizer reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial ...

Pfizer (NYSE:PFE) Price Target Cut to $29.00 by Analysts at Citigroup

Pfizer (NYSE:PFE – Get Free Report) had its price objective decreased by equities research analysts at Citigroup from $30.00 ...

Pfizer beats Q4, FY '24 earnings estimates, stock flat in premarket trading

Pfizer ( PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations ...

Hosted on MSN12h

Amgen, Merck and Pfizer Release Latest Quarterly Earnings, Share 2025 Plans

Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results